Prothena corporation plc share price

Mar 03, 2020 · Prothena Corporation plc ("Prothena" or the "Company") is a clinical-stage neuroscience company with expertise in protein misfolding, focused on …

Prothena Corporation PLC, PRTA:NSQ summary - FT.com Latest Prothena Corporation PLC (PRTA:NSQ) share price with interactive charts, historical prices, comparative analysis, Prothena Corporation Public Limited Company is a global biotechnology company. Share price information may be rounded up/down and therefore not entirely accurate. PRTA:NASDAQ GS Stock Quote - Prothena Corp PLC - Bloomberg ... About Prothena Corp PLC Prothena Corporation Public Limited Company operates as a biotechnology company. The Company focuses on the discovery and development of novel antibodies for … PRTA Stock | PROTHENA Stock Price Today | Markets Insider Prothena Corp. Plc is a late-stage clinical biotechnology company, which research, development and commercialization of therapies in the neuroscience and orphan categories.

Prothena Corporation PLC (PRTA:NSQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates.

Prothena Ord Share Price. 0Y3M - Stock Quote, Charts ... Prothena Corporation Plc Prothena Ord Shs is listed on the London Stock Exchange, trading with ticker code 0Y3M. It has a market capitalisation of $451m, with approximately 40m shares in issue. Prothena Corporation PLC, PRTA:NSQ summary - FT.com Latest Prothena Corporation PLC (PRTA:NSQ) share price with interactive charts, historical prices, comparative analysis, Prothena Corporation Public Limited Company is a global biotechnology company. Share price information may be rounded up/down and therefore not entirely accurate. PRTA:NASDAQ GS Stock Quote - Prothena Corp PLC - Bloomberg ... About Prothena Corp PLC Prothena Corporation Public Limited Company operates as a biotechnology company. The Company focuses on the discovery and development of novel antibodies for …

Fundamental analysis data for Prothena Corporation PLC (PRTA), including price-earnings ratios and earnings per share, at Ally Invest. Quotes Snapshot > PRTA. Prothena Corporation PLC PRTA:NASDAQ. Set Alert Options Streaming Charts. Last Price $11.17 Cboe Real-Time Last Sale as of 1:53PM ET 3/05/20

Apr 23, 2018 · Why Prothena Corporation plc Is Imploding Today That means that the company won't need to raise capital anytime soon, which is good news given where its share price is heading today. Prothena Corporation plc (PRTA) Stock Historical Prices ... 102 rows · Discover historical prices for PRTA stock on Yahoo Finance. View daily, weekly or monthly … Prothena Corporation plc (PRTA) Stock Price, Quote ... Find the latest Prothena Corporation plc (PRTA) stock quote, history, news and other vital information to help you with your stock trading and investing.

PRTA Stock Quote - Prothena Corporation plc Ordinary ...

The all-time high Prothena stock closing price was 75.31 on November 27, 2015 . The Prothena 52-week high stock price is 17.63 , which is 88.2% above the current share price. The Prothena 52-week low stock price is 6.71 , which is 28.4% below the current share price. The average Prothena stock price for the last 52 weeks is 10.50 . Prothena Corporation plc (PRTA) - Nasdaq

Prothena Corporation Public Limited Company is a global biotechnology company. The Company is focused on the discovery, development and commercialization of immunotherapies for the treatment of diseases that involve protein misfolding or cell adhesion.

INVESTOR RELATIONS | Prothena Corporation plc Feb 12, 2020 · Prothena Corporation plc (Nasdaq: PRTA) is a clinical-stage neuroscience company focused on the discovery and development of novel therapies with the potential to fundamentally change the course of progressive, life-threatening diseases.

Prothena Corporation plc, a clinical-stage neuroscience company, focuses on discovery and development of novel therapies for life-threatening diseases in the